Cargando…
Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study
BACKGROUND: there are dearths of studies describing the effect of autologous bone marrow derived stem cell transplantation (ABMSCT) through targeted approach in Type 2 Diabetes Mellitus. This study reports the efficacy and safety of super-selective injection of ABMSCT in T2DM. MATERIALS AND METHODS:...
Autores principales: | Bhansali, Anil, Upreti, Vimal, Walia, Rama, Gupta, Vivek, Bhansali, Shobhit, Sharma, R. R., Grover, Sandeep, Marwaha, Neelam, Khandelwal, Niranjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192991/ https://www.ncbi.nlm.nih.gov/pubmed/25364680 http://dx.doi.org/10.4103/2230-8210.140257 |
Ejemplares similares
-
Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods
por: Sood, Vikas, et al.
Publicado: (2017) -
Metformin upregulates mitophagy in patients with T2DM: A randomized placebo‐controlled study
por: Bhansali, Shipra, et al.
Publicado: (2020) -
Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity
por: Bhansali, Shobhit, et al.
Publicado: (2017) -
Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus – A pilot study
por: Shanmugasundar, G., et al.
Publicado: (2012) -
Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
por: Parthan, Girish, et al.
Publicado: (2018)